Aptahem AB
556970-5782ActiveBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Overview
- 0
- Employees
- -1 SEK
- Revenue
- 2014
- Founded
Key Decision Makers
Mikael Lindstam
CEO
Description
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556970578201
Decision Makers
1 contacts in FunnelfeedrMikael Lindstam
CEO
Similar Companies
20 similar companies in FunnelfeedrOblique Therapeutics AB (publ)
10–19 employeesInnovative biotech developing breakthrough antibodies using the AbiProt platform.
Modus Therapeutics Holding AB
1–4 employeesSwedish biotech developing sevuparin for severe inflammatory conditions.
Sangair AB
3 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Ribocure Pharmaceuticals AB
20–49 employeesClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
IONLACE AB
9 employeesRewriting medicine timelines using AI and modular protein design.
Browse More
Aptahem AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo